A Study to Test Concussion Return to Baseline after Elective Craniotomy Procedure


About this study

The purpose of this study is to determine return to baseline (RTB) period after an elective craniotomy procedure using the ImPACT testing assessment.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients must be 18-70 years old.
  • Patients must have planned surgery for resection of an extra-axial tumor (e.g., pituitary tumor, or meningioma).) or for deep brain stimulation electrode placement.
  • Patients must have a Karnofsky performance status  > 90%.
  • Patients must have normal bone marrow function with hematocrit ≥ 26%, platelet ≥ 100.000 prior to entering this study.
  • Patients must be able to complete the ImPACT testing at baseline and post-operatively.
  • Patient or LAR willing to provide written informed consent.

Exclusion Criteria:

  • Patients with language barrier impeding them to properly understand the tasks of the test.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Robert Wharen, M.D.

Open for enrollment

Contact information:

Courtney Graddy CCRP



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer